Depression Updates and Selective Serotonin Reuptake Inhibitor Management
Primary Care: Clinics in Office Practice · 2026-06 · 53 (2) · 153-165
DOI: 10.1016/j.pop.2026.01.002 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Primary Care: Clinics in Office Practice, 2026-06. Verfasst von Matteo Leveroni und 2 weiteren Autor:innen. Beteiligte Einrichtung: UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manche…. Hauptthemen laut MEDLINE: Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Depression, Depressive Disorder. Die Arbeit nennt 50 Literaturangaben.
Themen: Depression
Abstract (Originalsprache)
Depression is a prevalent and increasing concern in primary care, particularly among adolescents. Evidence supports routine screening, which improves remission and symptom reduction in adults and perinatal populations. Both psychotherapy and pharmacotherapy are effective first-line treatments, with similar efficacy in reducing symptoms. Selective serotonin reuptake inhibitors (SSRIs) remain the preferred outpatient antidepressant, demonstrating superiority over placebo and comparable outcomes to other agents. Generally safe for pregnant, breastfeeding, and geriatric patients, SSRIs require thoughtful selection based on side effects, contraindications, and patient preferences. Primary care clinicians are central to providing individualized, evidence-based, and patient-centered management of depression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA. Electronic address: mle…
- UCI Family Health Center, 800 N. Main Street, Santa Ana, CA 92701, USA; University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA.
- University of California- Irvine Department of Family Medicine, 200 S. Manchester Avenue, Suite 835, Orange, CA 92868, USA.
Zitieren
APA
Leveroni, M., Jones, S., & Bell, S. (2026). Depression Updates and Selective Serotonin Reuptake Inhibitor Management. Primary Care: Clinics in Office Practice, 53(2), 153-165. https://doi.org/10.1016/j.pop.2026.01.002
Vancouver
Leveroni M, Jones S, Bell S. Depression Updates and Selective Serotonin Reuptake Inhibitor Management. Primary Care: Clinics in Office Practice. 2026;53(2):153-165. doi:10.1016/j.pop.2026.01.002
BibTeX
@article{Leveroni2026,
author = {Leveroni, Matteo and Jones, Shane and Bell, Samuel},
title = {Depression Updates and Selective Serotonin Reuptake Inhibitor Management},
journal = {Primary Care: Clinics in Office Practice},
year = {2026},
volume = {53},
number = {2},
pages = {153--165},
doi = {10.1016/j.pop.2026.01.002}
}
EUVIMED